Cargando…

Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion

BACKGROUND: Although clinical trials have reported favorable outcomes after drug‐coated balloon (DCB) therapy for femoropopliteal lesions, their real‐world performance and predictors have not been well evaluated. This study aimed to elucidate 1‐year freedom from restenosis and to explore the associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soga, Yoshimitsu, Takahara, Mitsuyoshi, Iida, Osamu, Tomoi, Yusuke, Kawasaki, Daizo, Tanaka, Akiko, Yamauchi, Yasutaka, Tobita, Kazuki, Kozuki, Amane, Fujihara, Masahiko, Ando, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973589/ https://www.ncbi.nlm.nih.gov/pubmed/36583431 http://dx.doi.org/10.1161/JAHA.122.025677

Ejemplares similares

Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Inverse association of diabetes and dialysis with the severity of femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Subintimal Versus Intraluminal Approach for Femoropopliteal Chronic Total Occlusions Treated With Intravascular Ultrasound Guidance
por: Tomoi, Yusuke, et al.
Publicado: (2021)

Prognostic Value of the CHA (2) DS (2) -VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions
por: Tomoi, Yusuke, et al.
Publicado: (2021)

Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation
por: Haraguchi, Takuya, et al.
Publicado: (2023)

Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry
por: Fujihara, Masahiko, et al.
Publicado: (2023)

One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2020)

Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Intravascular ultrasound-based decision tree model for the optimal endovascular treatment strategy selection of femoropopliteal artery disease—results from the ONION Study-
por: Yazu, Yuko, et al.
Publicado: (2022)

Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
por: Tobita, Kazuki, et al.
Publicado: (2023)

Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
por: Horie, Kazunori, et al.
Publicado: (2023)

Five-Year Patency and its Predictors after Endovascular Therapy for Aortoiliac Occlusive Disease
por: Nanto, Kiyonori, et al.
Publicado: (2019)

Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
por: Hayakawa, Naoki, et al.
Publicado: (2022)

One-Year Clinical Outcomes following Implantation of Innova™ Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions
por: Tsujimura, Takuya, et al.
Publicado: (2019)

Retrospective multicenter registry for endovascular treatment with newer devices in over 25‐cm femoropopliteal artery disease: A retrospective observational study
por: Horie, Kazunori, et al.
Publicado: (2022)

Effect of Target Lesion Revascularization on Restenosis Lesions of the Superficial Femoral Artery without Recurred Symptoms after Endovascular Therapy
por: Utsunomiya, Makoto, et al.
Publicado: (2021)

Presentation Pattern of Lower Extremity Endovascular Intervention versus Percutaneous Coronary Intervention
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)

Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

Platelet to lymphocyte ratio predicting 6-month primary patency of drug-coated balloon for femoropopliteal disease
por: Zhen, Yanhua, et al.
Publicado: (2020)

Impact of Peak Systolic Velocity Ratio after Drug-Coated Balloon for Femoropopliteal Disease: Three-Month Serial Observation Vessel Echo Study
por: Kawasaki, Daizo, et al.
Publicado: (2022)

Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia
por: Kodama, Akio, et al.
Publicado: (2022)

Clinical impact and risk stratification of balloon angioplasty for femoropopliteal disease in nitinol stenting era: Retrospective multicenter study using propensity score matching analysis
por: Tsuchiya, Taketsugu, et al.
Publicado: (2016)

Impact of number of run-off vessels on interwoven nitinol mesh stents patency in the femoropopliteal segment
por: Rigatelli, Gianluca, et al.
Publicado: (2020)

Lesion Characteristics Associated with Loss of Primary Patency After Endovascular Therapy for Common Femoral Artery Lesions
por: Yamauchi, Yasutaka, et al.
Publicado: (2023)

Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass
por: Rumba, Roberts, et al.
Publicado: (2023)

Outcomes of Dissection Angles as Predictor of Restenosis after Drug-Coated Balloon Treatment
por: Kozuki, Amane, et al.
Publicado: (2021)

In-Hospital Outcomes after Endovascular Therapy for Acute Limb Ischemia: A Report from a Japanese Nationwide Registry [J-EVT Registry]
por: Tsujimura, Takuya, et al.
Publicado: (2021)

Impact of Hospital Volume on Clinical Outcomes after Aortoiliac Stenting in Patients with Peripheral Artery Disease
por: Iida, Osamu, et al.
Publicado: (2020)

Clinical Impact of Measures for Frailty Severity in Poor-Risk Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency()
por: Marples, Rory, et al.
Publicado: (2021)

Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia)
por: Iida, Osamu, et al.
Publicado: (2017)

Impact of homocysteine levels on mortality risk in patients with chronic limb-threatening ischemia undergoing revascularization
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

The Association of Preoperative Characteristics with Reintervention Risk in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia
por: Iida, Osamu, et al.
Publicado: (2021)

Current and Past Obesity in Japanese Patients with Critical Limb Ischemia Undergoing Revascularization
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Social isolation in patients with chronic limb-threatening ischemia: a cross-sectional study
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Injury Precipitating Tissue Loss and Time to Referral to a Vascular Center in Patients with Chronic Limb-Threatening Ischemia
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9brkp5j70qll58verm75gqnfj6